Experimental Radiotracer Imaging Study for Cancer Patients

Enter your info and the study team will contact you soon!
Your data is securely stored and only shared with the research team
Logo Image
"Volunteer for research at UC Davis and contribute to discoveries that may improve health care for you, your family, and your community!"
Age: 18 years or older
Gender:
Any
Healthy Volunteers: No
Keywords: carcinoma, PET, cancer, radiotracer
Type: Drug study, Phase 1
Target:
27 Participants
Investigator:
Description
We invite you to take part in a research study because you have been diagnosed with cancer.

Researchers at UC Davis have developed a new drug to aid in the detection of cancer. This drug, called a “radiotracer,” attaches to cancer cells and shines a light that can be seen using a special camera, called a “positron emission tomography” or “PET” scanner. We hope this new radiotracer will improve the ability to locate cancer in the body. This new experimental radiotracer is called Fluorine-18 Alpha-V Beta-6 Binding Peptide.
This study requires

About 24 hours before your PET scan, we will ask you to come to the clinic for a blood draw. On the day of your PET scan you will participate for about 5 hours. We will then ask you to come back to the clinic for a blood draw - 24 hours and 1 week after your PET scan. We will then check on your progress, using your medical record, for up to 6 months after your direct participation.

Contact study team for more details or see attached informed consent

Who can participate

Inclusion Criteria:

  • Diagnosed with primary or metastatic cancer in one or more of the following locations: breast, colorectal, lung, pancreas

  • Eastern Cooperative Oncology Group (ECOG) performance score of 0-1

  • Will sign the Institutional Review Board (IRB)-approved consent form

  • Able to remain motionless for up to 30-60 minutes per scan

Exclusion Criteria:

  • Creatinine > 2 x upper limit of normal

  • Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) > 2 x upper limit of normal

  • Life expectancy < 3 months (mo)

  • Women who are pregnant or breast-feeding

  • Patients who cannot undergo PET/compute tomography (CT) scanning

  • Lack of availability for follow-up assessments

  • Participation in another clinical trial involving an investigational agent within 4 weeks of enrollment

Benefits and risks of participating
We cannot promise any benefits to you from participating in this research. Your doctor will inform you of the risks associated with this study.
Compensation
$25 Gift card
Resources
PDF Docs
Schedule
Study duration and period
We expect that you will be in this research study for one week.
Recruitment period
From Nov. 16, 2016 to Oct. 22, 2018
Location
UC Davis Ambulatory Care Center
4860 Y Street
Suite 0500
Sacramento, CA 95817
Research Topic
Conditions:
  • Breast Carcinoma
  • Colorectal Carcinoma
  • Lung Carcinoma
  • Metastatic Malignant Neoplasm in the Breast
  • Metastatic Malignant Neoplasm in the Colon
  • Metastatic Malignant Neoplasm in the Lung
  • Metastatic Malignant Neoplasm in the Rectum
  • Pancreatic Carcinoma

Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.


Sending

Send SMS with Study Info:

SMS Sent!

Share Study Info via Email:


E-mail Preview